Himalaya Therapeutics Announces Highlights of Recent Clinical Progress
Mecbotamab vedotin (BA3011) Phase 2 part 1 interim results in NSCLC continue to show antitumor activity with additional patients enrolled HTBA3011 Undifferentiated Pleomorphic Sarcoma (UPS) enrollment in Phase 2 part 2 of study anticipated to begin by year-end CAB-CTLA-4 (HTBA3071) Phase 1 study ongoing in tumor types responsive to CTLA-4 inhibition...
Amorepacific publishes its findings on dietary restrictions and lifespan extension in Nature Communications
Discovered the effects of the essential amino acid, threonine, on promoting both life and healthspans. Research findings will be applied to product development of its brand, VITAL BEAUTIE. SEOUL, South Korea, Nov. 8, 2022 /PRNewswire/ -- Amorepacific discovered a mechanism of dietary restriction for lifespan extension in the essential amino...
Insilico Medicine Signs Strategic Research Collaboration with Sanofi worth up to $1.2 Billion
Agreement includes aggregate upfront and target nomination fees of up to $21.5 million for up to 6 targets, and additional R&D and sales milestones plus tier-based mid-single- to low double-digit royalties. New York , Nov. 8, 2022 /PRNewswire/ -- Insilico Medicine, a clinical stage artificial intelligence (AI)-driven drug discovery company, announced a multi-year, multi-target strategic research collaboration with Sanofi. Under...
XJTLU and University of Liverpool to inaugurate Joint Centre for Pharmacology and Therapeutics
SUZHOU, China, Nov. 8, 2022 /PRNewswire/ -- On 11 November, Xi'an Jiaotong-Liverpool University (XJTLU) and the University of Liverpool will inaugurate their Joint Centre for Pharmacology and Therapeutics at an online/onsite event in Suzhou, China. Xi'an Jiaotong-Liverpool University (XJTLU) researchers conduct world-class biopharmaceutical research at the University's Suzhou Industrial Park (SIP) campus. XJTLU and...
Novavax Phase 3 COVID-19 Omicron Trial Supports the Continued and Future Use of Novavax Prototype Vaccine as a Booster
The Novavax BA.1 vaccine candidate met its primary strain-change endpoint allowing for development of variant vaccines, if necessary Novavax' prototype vaccine induced broad immune response against original Wuhan, BA.1, and BA.5 strains The trial showed no benefit for a bivalent vaccine utilizing Novavax' recombinant protein/adjuvant technology GAITHERSBURG,...
Ascom Applauded by Frost & Sullivan for Improving Hospital Medical Device Workflows with Its MDI Platform
The Medical Device Integration Platform visualizes data and events from medical devices on dashboards and sends actionable insights and alarms to caregivers, supporting their activities while on the move. SAN ANTONIO, Nov. 8, 2022 /PRNewswire/ -- Frost & Sullivan recently analyzed the global medical devices connectivity industry and, based on its research findings,...
Omega Healthcare Named a Leader in Medical Coding Operations PEAK Matrix® Assessment 2023
Adds to recent designation of a Star Performer for RCM Operations by Everest Group BOCA RATON, Fla., Nov. 8, 2022 /PRNewswire/ -- Omega Healthcare, a leading healthcare management solutions partner supporting the broad healthcare ecosystem, was named a "Leader" in Medical Coding Operations PEAK Matrix® Assessment 2023 by Everest Group, a research firm...
Traditional Chinese Medicine Lianhua Qingwen Attracted Eyes in the Annual National Conference of Pharmaceutical Society of Nigeria
SHIJIAZHUANG, China, Nov. 8, 2022 /PRNewswire/ -- Recently, the 95th National Annual Conference of the Pharmaceutical Society of Nigeria was held in Jos, capital of Plateau State. The theme of the Conference in this year was "Medicine Security in an Unstable Economy", and more than 3,000 doctors and experts attended the event offline and online. Also attending the event...
Zepp Health Corporation to Report Third Quarter 2022 Financial Results on November 21, 2022
Earnings Call Scheduled for 7:30 a.m. ET on November 21, 2022 BEIJING, Nov. 8, 2022 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE: ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that it will report its third quarter 2022 unaudited financial results before the market open on Monday, November 21, 2022. Management will hold a...
EIT Health’s Venture Centre of Excellence Names ProductLife Group as Privileged Partner for Regulatory & Compliance
The ambitious EU initiative has already secured 2 billion euros of co-investment capabilities and has supported 60 innovative Biotech, Medtech & digital health start-ups to get to market or expand into new territories. EIT Health, co-operator of the Venture Centre of Excellence alongside the European Investment Fund (EIF), has named ProductLife Group the exclusive Privileged Partner for Regulatory...
